Christopher Espelin, based in Cambridge, Massachusetts, United States, is currently a Sr. Director-Pharmacology and Translational Sciences at Mediar Therapeutics, bringing experience from previous roles at ImmunoGen, Inc., Merrimack, Pfizer and Harvard Medical School. Christopher Espelin holds a PhD in Biology (Biochemistry) @ Massachusetts Institute of Technology. With a robust skill set that includes Leadership, Computational Biology, High Throughput Screening, Systems Biology, Cell Biology and more, Christopher Espelin contributes valuable insights to the industry. Christopher Espelin has 2 emails on RocketReach.